Cellular glucose transport and glucotransporter 4 expression as a therapeutic target: clinical and experimental studies-Reference-Cited by-同舟云学术

Cellular glucose transport and glucotransporter 4 expression as a therapeutic target: clinical and experimental studies

Published:2009-11-03 Issue:6 Volume:57 Page:
ISSN:0004-069X
Container-title:Archivum Immunologiae et Therapiae Experimentalis
language:en
Short-container-title:Arch. Immunol. Ther. Exp.

Author:

Czech Anna,Piątkiewicz Paweł,Tatoń Jan

Publisher

Springer Science and Business Media LLC

Subject

General Medicine,Immunology,Immunology and Allergy

Link

https://link.springer.com/content/pdf/10.1007/s00005-009-0052-7.pdf

Reference31 articles.

1. Almer LO (1984) Effects of chlorpropamide and gliclazide on plasminogen activator activity in vascular walls in patients with maturity onset diabetes. Thromb Res 35: 19–25

2. Armitage P (1971) Statistical methods in medical research, 3rd ed. Blackwell Scientific Publication, Oxford

3. Chakrabarti R, Jung CY, Lee TP et al (1994) Changes in glucose transport and transporter isoforms during the activation of human peripheral blood lymphocytes by phytohemagglutinin. J Immunol 152: 2660–2668

4. Curto M, Piccinini M, Rabbone I et al (1997) G proteins and regulation of pyruvate dehydrogenase activity by insulin in human circulating lymphocytes. Int J Biochem Cell Biol 29: 1207–1217

5. Czech MP, Corvera S (1999) Signaling mechanisms that regulate glucose transport. J Biol Chem 274: 1865–1868

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Dynamic Changes of BVRA Protein Levels Occur in Response to Insulin: A Pilot Study in Humans;International Journal of Molecular Sciences;2023-04-14

2. Biliverdin reductase-A protein levels are reduced in type 2 diabetes and are associated with poor glycometabolic control;Life Sciences;2021-11

3. Reduced biliverdin reductase-A levels are associated with early alterations of insulin signaling in obesity;Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease;2019-06

4. The Dysfunction of NK Cells in Patients with Type 2 Diabetes and Colon Cancer;Archivum Immunologiae et Therapiae Experimentalis;2013-03-02